Jonathan Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jonathan Cohen has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
Julia Kenny
Paediatric Immunology and Infectious Diseases, Evelina London Children’s Hospital, London, UK
4 shared publicationsShamez Ladhani
Immunisation Division, UK Health Security Agency, London, United Kingdom
4 shared publicationsSarah Eisen
Paediatric & Adolescent Division, University College London Hospitals NHS Foundation Trust, London, UK
3 shared publications- Sarah Eisen
Children and Young People’s Division/Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, UK
3 shared publications Aislinn Jennings
Department of Women and Children’s Health, School of Life Course and Population Sciences, King’s College London, St Thomas’ Hospital, London, UK
2 shared publications- Aubrey J. Cunnington
Imperial College London
2 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (12) , e484-e491
A Retrospective Study of the Management of Pediatric Cutaneous Leishmaniasis in a Non-endemic Setting
Introduction: Cutaneous leishmaniasis (CL), caused by protozoa of the genus Leishmania , is a neglected tropical disease. Limited evidence exists to inform the management of CL in children and adolescents, and experience in non-endemic settings varies significantly. We report case data and treatment outcomes for 17 children and young people diagnosed with CL and treated at a specialist tropical medicine center in the United Kingdom. Methods: The electronic patient records of 17 patients less than 18 years old with CL who were treated at University College London Hospitals between October 2015 and June 2025 were accessed to gather data including demographics (age, sex, country of origin), likely country of CL acquisition, causative species of Leishmania , treatment given and treatment outcome. Causative agents included L. donovani complex (n = 6), L. major (n = 5), L. tropica (n = 4), L. Viannia subgenus (n = 1) and a Leishmania species where subgenus or species could not be determined (n = 1). Results: Conservative management (2/17), oral miltefosine (9/17), intralesional meglumine antimoniate (3/17) and intravenous liposomal amphotericin B (LAMB; 3/17) were used as first-line treatment approaches in this cohort. Two patients were lost to follow-up, but complete resolution was observed in 14 of the remaining 15 patients by day 180 post-treatment initiation, with 1 child’s lesion taking longer than this to fully re-epithelialize. Adverse effects of treatment were observed in 6/17 (35%) patients and were mild or moderate. Conclusions: Our data show that miltefosine, intralesional meglumine antimoniate and LAMB are effective, safe and well-tolerated treatments for children with CL in non-endemic settings. Management of children and young adults with CL may present additional complexity compared to adults, such as difficulty obtaining biopsy samples, lack of evidence for drug dosing regimens and tolerability of painful injections, which need to be administered repeatedly. Individualized treatment decisions should be made in conjunction with children, young people and their families, and a multidisciplinary approach is recommended.
- 17 July 2026
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 45 (12) , e484-e491
Open AccessA Retrospective Study of the Management of Pediatric Cutaneous Leishmaniasis in a Non-endemic Setting
Introduction: Cutaneous leishmaniasis (CL), caused by protozoa of the genus Leishmania , is a neglected tropical disease. Limited evidence exists to inform the management of CL in children and adolescents, and experience in non-endemic settings varies significantly. We report case data and treatment outcomes for 17 children and young people diagnosed with CL and treated at a specialist tropical medicine center in the United Kingdom. Methods: The electronic patient records of 17 patients less than 18 years old with CL who were treated at University College London Hospitals between October 2015 and June 2025 were accessed to gather data including demographics (age, sex, country of origin), likely country of CL acquisition, causative species of Leishmania , treatment given and treatment outcome. Causative agents included L. donovani complex (n = 6), L. major (n = 5), L. tropica (n = 4), L. Viannia subgenus (n = 1) and a Leishmania species where subgenus or species could not be determined (n = 1). Results: Conservative management (2/17), oral miltefosine (9/17), intralesional meglumine antimoniate (3/17) and intravenous liposomal amphotericin B (LAMB; 3/17) were used as first-line treatment approaches in this cohort. Two patients were lost to follow-up, but complete resolution was observed in 14 of the remaining 15 patients by day 180 post-treatment initiation, with 1 child’s lesion taking longer than this to fully re-epithelialize. Adverse effects of treatment were observed in 6/17 (35%) patients and were mild or moderate. Conclusions: Our data show that miltefosine, intralesional meglumine antimoniate and LAMB are effective, safe and well-tolerated treatments for children with CL in non-endemic settings. Management of children and young adults with CL may present additional complexity compared to adults, such as difficulty obtaining biopsy samples, lack of evidence for drug dosing regimens and tolerability of painful injections, which need to be administered repeatedly. Individualized treatment decisions should be made in conjunction with children, young people and their families, and a multidisciplinary approach is recommended.
- 9 January 2025
- Published by BMJ in Archives of Disease in Childhood
- Vol. 110 (5) , 411.2-412
Opportunistic vaccination in a children’s hospital outpatients department
- 9 January 2025
- Published by BMJ in Archives of Disease in Childhood
- Vol. 110 (5) , 411.2-412
Opportunistic vaccination in a children’s hospital outpatients department
- Open Access
- 19 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
Severe febrile illnesses in children encompass life-threatening organ dysfunction caused by diverse pathogens and other severe inflammatory syndromes. A comparative approach to these illnesses may identify shared and distinct features of host immune dysfunction amenable to immunomodulation. Here, using immunophenotyping with mass cytometry and cell stimulation experiments, we illustrate trajectories of immune dysfunction in 74 children with multi-system inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2, 30 with bacterial infection, 16 with viral infection, 8 with Kawasaki disease, and 42 controls. We explore these findings in a secondary cohort of 500 children with these illnesses and 134 controls. We show that neutrophil activation and apoptosis are prominent in multi-system inflammatory syndrome, and that this is partially shared with bacterial infection. We show that memory T cells from patients with multi-system inflammatory syndrome and bacterial infection are exhausted. In contrast, we show viral infection to be characterized by a distinct signature of decreased interferon signaling and lower interferon receptor gene expression. Improved understanding of immune dysfunction may improve approaches to immunomodulator therapy in severe febrile illnesses in children.
- 19 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessShared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
Severe febrile illnesses in children encompass life-threatening organ dysfunction caused by diverse pathogens and other severe inflammatory syndromes. A comparative approach to these illnesses may identify shared and distinct features of host immune dysfunction amenable to immunomodulation. Here, using immunophenotyping with mass cytometry and cell stimulation experiments, we illustrate trajectories of immune dysfunction in 74 children with multi-system inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2, 30 with bacterial infection, 16 with viral infection, 8 with Kawasaki disease, and 42 controls. We explore these findings in a secondary cohort of 500 children with these illnesses and 134 controls. We show that neutrophil activation and apoptosis are prominent in multi-system inflammatory syndrome, and that this is partially shared with bacterial infection. We show that memory T cells from patients with multi-system inflammatory syndrome and bacterial infection are exhausted. In contrast, we show viral infection to be characterized by a distinct signature of decreased interferon signaling and lower interferon receptor gene expression. Improved understanding of immune dysfunction may improve approaches to immunomodulator therapy in severe febrile illnesses in children.
- 16 April 2024
- Published by BMJ in Archives of Disease in Childhood
- Vol. 110 (2) , 89-93
Parasitic infections: what do paediatricians need to know?
Parasitic infections and the medications used to treat them may be unfamiliar to many paediatricians. Parasitic infections, however, are not uncommonly seen in children in the UK. We summarise infections which are commonly seen, currently recommended treatment and practical guidance on formulations, adverse effects and treatment choice.
- 16 April 2024
- Published by BMJ in Archives of Disease in Childhood
- Vol. 110 (2) , 89-93
Parasitic infections: what do paediatricians need to know?
Parasitic infections and the medications used to treat them may be unfamiliar to many paediatricians. Parasitic infections, however, are not uncommonly seen in children in the UK. We summarise infections which are commonly seen, currently recommended treatment and practical guidance on formulations, adverse effects and treatment choice.
- Open Access
- 28 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0285646
Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study
Background: Radiotherapy has an important role in the treatment of brain metastases but carries risk of short and/or long-term toxicity, termed radiation-induced brain injury (RBI). As the diagnosis of RBI is crucial for correct patient management, there is an unmet need for reliable biomarkers for RBI. The aim of this proof-of concept study is to determine the utility of brain-derived circulating free DNA (BncfDNA), identified by specific methylation patterns for neurons, astrocytes, and oligodendrocytes, as biomarkers brain injury induced by radiotherapy. Methods: Twenty-four patients with brain metastases were monitored clinically and radiologically before, during and after brain radiotherapy, and blood for BncfDNA analysis (98 samples) was concurrently collected. Sixteen patients were treated with whole brain radiotherapy and eight patients with stereotactic radiosurgery. Results: During follow-up nine RBI events were detected, and all correlated with significant increase in BncfDNA levels compared to baseline. Additionally, resolution of RBI correlated with a decrease in BncfDNA. Changes in BncfDNA were independent of tumor response. Conclusions: Elevated BncfDNA levels reflects brain cell injury incurred by radiotherapy. further research is needed to establish BncfDNA as a novel plasma-based biomarker for brain injury induced by radiotherapy.
- 28 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0285646
Open AccessShort report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study
Background: Radiotherapy has an important role in the treatment of brain metastases but carries risk of short and/or long-term toxicity, termed radiation-induced brain injury (RBI). As the diagnosis of RBI is crucial for correct patient management, there is an unmet need for reliable biomarkers for RBI. The aim of this proof-of concept study is to determine the utility of brain-derived circulating free DNA (BncfDNA), identified by specific methylation patterns for neurons, astrocytes, and oligodendrocytes, as biomarkers brain injury induced by radiotherapy. Methods: Twenty-four patients with brain metastases were monitored clinically and radiologically before, during and after brain radiotherapy, and blood for BncfDNA analysis (98 samples) was concurrently collected. Sixteen patients were treated with whole brain radiotherapy and eight patients with stereotactic radiosurgery. Results: During follow-up nine RBI events were detected, and all correlated with significant increase in BncfDNA levels compared to baseline. Additionally, resolution of RBI correlated with a decrease in BncfDNA. Changes in BncfDNA were independent of tumor response. Conclusions: Elevated BncfDNA levels reflects brain cell injury incurred by radiotherapy. further research is needed to establish BncfDNA as a novel plasma-based biomarker for brain injury induced by radiotherapy.
- Open Access
- 4 October 2023
- Published by Springer Nature in Research Square
Immunology of severe febrile illness in children in the COVID-19 era
Severe febrile illnesses in children, such as multi-system inflammatory syndrome in children (MIS-C), severe bacterial infection (SBI), severe viral infection (SVI), and Kawasaki disease (KD), have shared clinical features. We used immunophenotyping with mass cytometry and cell stimulation experiments to illustrate shared and distinct mechanisms of immune dysfunction in 74 children with MIS-C, 30 with SBI, 16 with SVI, 8 with KD, and 42 controls. We then used targeted gene expression analysis to explore these findings in a secondary cohort of 500 children with these illnesses and 134 controls. Immunophenotyping and clustering analysis revealed neutrophil activation and apoptosis and T cell activation to be prominent in MIS-C and SBI. Cell stimulation experiments showed T cells from patients with acute MIS-C were exhausted. SVI was characterized by phosphorylated STAT signaling but lower gene expression for interferon receptors. Improved understanding of immune dysfunction may improve immunomodulator therapy in severe childhood febrile illnesses.
- 4 October 2023
- Published by Springer Nature in Research Square
Open AccessImmunology of severe febrile illness in children in the COVID-19 era
Severe febrile illnesses in children, such as multi-system inflammatory syndrome in children (MIS-C), severe bacterial infection (SBI), severe viral infection (SVI), and Kawasaki disease (KD), have shared clinical features. We used immunophenotyping with mass cytometry and cell stimulation experiments to illustrate shared and distinct mechanisms of immune dysfunction in 74 children with MIS-C, 30 with SBI, 16 with SVI, 8 with KD, and 42 controls. We then used targeted gene expression analysis to explore these findings in a secondary cohort of 500 children with these illnesses and 134 controls. Immunophenotyping and clustering analysis revealed neutrophil activation and apoptosis and T cell activation to be prominent in MIS-C and SBI. Cell stimulation experiments showed T cells from patients with acute MIS-C were exhausted. SVI was characterized by phosphorylated STAT signaling but lower gene expression for interferon receptors. Improved understanding of immune dysfunction may improve immunomodulator therapy in severe childhood febrile illnesses.
- 7 September 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (12) , 1051-1055
Infections in Asymptomatic Unaccompanied Asylum-seeking Children in London 2016–2022
Background: Unaccompanied asylum-seeking children are at increased risk of infections and experience barriers to healthcare access. There is a lack of evidence to underpin existing national and international guidance regarding asymptomatic infection screening in this population. We describe the results from routine infection screening of 1104 unaccompanied asylum-seeking children attending for testing at 3 London centers. Methods: We performed a retrospective analysis of routinely collected data from all unaccompanied asylum-seeking children seen in 3 services in London, United Kingdom, between 2016 and 2022. Results: A total of 1104 unaccompanied asylum-seeking children attended clinic; all accepted screening. The median age was 16 years (range 11–18 years) and 987 (89%) were male. 407 (37%) had at least 1 infection; 116 (11%) had multiple infections. Tuberculosis infection and schistosomiasis were common (found in 18% and 17%, respectively). Hepatitis B infection was identified with a prevalence of 3.9%. Giardia 7.7%, tapeworm 3.3% and Strongyloides 2.8% were also commonly identified. Conclusions: We report the largest known dataset to our knowledge of infection screening in asymptomatic unaccompanied asylum-seeking children in Europe to date. This data supports recommendations for routine asymptomatic screening in this high-risk cohort, based on the significant prevalence identified of infections of both personal and public health significance.
- 7 September 2023
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (12) , 1051-1055
Infections in Asymptomatic Unaccompanied Asylum-seeking Children in London 2016–2022
Background: Unaccompanied asylum-seeking children are at increased risk of infections and experience barriers to healthcare access. There is a lack of evidence to underpin existing national and international guidance regarding asymptomatic infection screening in this population. We describe the results from routine infection screening of 1104 unaccompanied asylum-seeking children attending for testing at 3 London centers. Methods: We performed a retrospective analysis of routinely collected data from all unaccompanied asylum-seeking children seen in 3 services in London, United Kingdom, between 2016 and 2022. Results: A total of 1104 unaccompanied asylum-seeking children attended clinic; all accepted screening. The median age was 16 years (range 11–18 years) and 987 (89%) were male. 407 (37%) had at least 1 infection; 116 (11%) had multiple infections. Tuberculosis infection and schistosomiasis were common (found in 18% and 17%, respectively). Hepatitis B infection was identified with a prevalence of 3.9%. Giardia 7.7%, tapeworm 3.3% and Strongyloides 2.8% were also commonly identified. Conclusions: We report the largest known dataset to our knowledge of infection screening in asymptomatic unaccompanied asylum-seeking children in Europe to date. This data supports recommendations for routine asymptomatic screening in this high-risk cohort, based on the significant prevalence identified of infections of both personal and public health significance.
- 20 October 2022
- Published by Elsevier in Journal of Infection
- Vol. 85 (6) , 702-769
The changing epidemiology of PIMS-TS across COVID-19 waves: prospective national surveillance, January 2021 to July 2022, England
- 20 October 2022
- Published by Elsevier in Journal of Infection
- Vol. 85 (6) , 702-769
The changing epidemiology of PIMS-TS across COVID-19 waves: prospective national surveillance, January 2021 to July 2022, England
- Open Access
- 7 September 2022
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 21, 100514
Care of children exposed to monkeypox
- 7 September 2022
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 21, 100514
Open AccessCare of children exposed to monkeypox
- 2 September 2022
- Published by BMJ in Archives of Disease in Childhood
- Vol. 107 (12) , 1065-1066
Monkeypox and children
- 2 September 2022
- Published by BMJ in Archives of Disease in Childhood
- Vol. 107 (12) , 1065-1066
Monkeypox and children